FDA Panel Votes to Modify Isotretinoin iPLEDGE REMS : vimars

Advisory committee members voted to recommend changing the 19-day lockout for the drug for severe, nodular acne and the monthly attestation requirement for counseling people who cannot get pregnant.

Related Keywords

San Francisco , California , United States , Minnesota , Megha Tollefson , Ken Katz , Kaiser Permanente , Ophthalmic Drugs Advisory Committee , Risk Management Advisory Committee , Drug Administration , Mitigation Strategy , Mayo Clinic , Patient Safety , Isotretinoin , Acne , Acne Vulgaris , Skin And Soft Tissue Infection , Pregnancy , Risk Evaluation And Mitigation Strategies Rems , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda ,